Steven M. Chan

6.3k citations

94 papers · 3.7k indexed · 3 hit papers · h-index 25

Impact in

Hematology top 0.5%
- Acute Myeloid Leukemia Research
Cancer Research top 2%
- Cancer Genomics and Diagnostics

Papers in

Hematology 55
- Acute Myeloid Leukemia Research 50
- Chronic Myeloid Leukemia Treatments 14
Genetics 15
- Myeloproliferative Neoplasms: Diagnosis and Treatment 10

Co-authors: Ravindra Majeti Paul J. Utz M. Ryan Corces Bruno C. Medeiros Scott V. Bratman David W. Cescon Lillian L. Siu Danièl Thomas
Journals: Blood (32 papers)Leukemia (4 papers)Nature Medicine (2 papers)British Journal of Haematology (2 papers)Nature Communications (2 papers)
Partner nations: Canada United States India

In The Last Decade

Steven M. Chan

83 papers receiving 3.7k citations

Hit Papers

align trajectories log scale

Circulating tumor DNA and liquid biopsy in oncology 2020 · 382 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2020 Nature Cancer
2016 Nature Genetics
2015 Nature Medicine

Peers

Countries citing papers authored by Steven M. Chan

Since Specialization

Citations

This map shows the geographic impact of Steven M. Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven M. Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven M. Chan more than expected).

Fields of papers citing papers by Steven M. Chan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven M. Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven M. Chan. The network helps show where Steven M. Chan may publish in the future.

Co-authors

The 25 scholars most cited alongside Steven M. Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Steven M. Chan Line = papers co-authored together Steven M. Chan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Novel and emerging therapeutic strategies for clonal haematopoiesis Haematologica ·Mohsen Hosseini, Steven M. Chan	2025	0
2	Identifying Risk Factors and Outcome for CNS Involvement in AML Clinical Lymphoma Myeloma & Leukemia ·Jack T Seki, Georgina S. Daher-Reyes, Eshetu G. Atenafu, Jad Sibai, Aniket Bankar, Tayler Young, Steven M. Chan, Karen Yee, Vikas Gupta, Mark D. Minden, Dawn Maze, Andre C. Schuh, Aaron D. Schimmer, Hassan Sibai	2025	0
3	Flow cytometry-based measurable residual disease (MRD) analysis identifies AML patients who may benefit from allogeneic hematopoietic stem cell transplantation Annals of Hematology ·Josephine Anne Lucero, Muhned Alhumaid, Igor Novitzky‐Basso, José‐Mario Capo‐Chichi, Tracy Stockley, Vikas Gupta, Aniket Bankar, Steven M. Chan, Andre C. Schuh, Mark D. Minden, Jonas Mattsson, Rajat Kumar, Hassan Sibai, Anne Tierens, Dennis Dong Hwan Kim	2024	3
4	FLAG-IDA Plus Venetoclax in High-Risk Newly Diagnosed and Relapsed or Refractory Acute Myeloid Leukemia: The Princess Margaret Cancer Center Experience Blood ·Eshrak Al‐Shaibani, Marta Davidson, Aniket Bankar, Steven M. Chan, Hassan Sibai, Dawn Maze, Aaron D. Schimmer, Mark D. Minden, Karen Yee, Vikas Gupta, Andre C. Schuh, Guillaume Richard‐Carpentier	2024	0
5	Breakthrough Invasive Fungal Infection After Coadministration of Venetoclax and Voriconazole Open Forum Infectious Diseases ·Victoria Hall, Kenny Tang, Deepali Kumar, Coleman Rotstein, Signy Chow, Steven M. Chan, Shahid Husain, Seyed M. Hosseini‐Moghaddam	2023	5
6	Impact of Geographical Distance from Quaternary Treatment Center on Clinical Trial Participation, Intensive Induction Chemotherapy, and Outcomes in Patients with Newly Diagnosed Acute Myeloid Leukemia Acta Haematologica ·Samantha Hershenfeld, Eshetu G. Atenafu, Steven M. Chan, Vikas Gupta, Dawn Maze, Andre C. Schuh, Hassan Sibai, Karen Yee, Arron D Schimmer	2023	1
7	Safety of re‐challenging adults with acute lymphoblastic leukemia with PEG‐asparaginase‐induced severe hypertriglyceridemia when treated with a pediatric‐inspired regimen SHILAP Revista de lepidopterología ·Ibrahim Al Nabhani, Claire Andrews, Jad Sibai, Eshetu G. Atenafu, Taylor Young, Steven M. Chan, Vikas Gupta, Dawn Maze, Aaron D. Schimmer, Andre C. Schuh, Karen Yee, Hassan Sibai	2022	2
8	Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness Cancer Research ·Alex C.H. Liu, Séverine Cathelin, Yitong Yang, David L. Dai, Dhanoop Manikoth Ayyathan, Mohsen Hosseini, Mark D. Minden, Anne Tierens, Steven M. Chan	2022	13
9	An integrative systems biology approach to overcome venetoclax resistance in acute myeloid leukemia PLoS Computational Biology ·Michelle Przedborski, David Sharon, Séverine Cathelin, Steven M. Chan, Mohammad Kohandel	2022	2
10	Circulating tumor DNA and liquid biopsy in oncology Nature Cancer ·David W. Cescon, Scott V. Bratman, Steven M. Chan, Lillian L. Siu Hit paper breakdown →	2020	382
11	Optimizing survival outcomes with post‐remission therapy in acute myeloid leukemia American Journal of Hematology ·Bruno C. Medeiros, Steven M. Chan, Naval Daver, Brian A. Jonas, Daniel A. Pollyea	2019	60
12	Combination of Enasidenib and Venetoclax Shows Superior Anti-Leukemic Activity Against IDH2 Mutated AML in Patient-Derived Xenograft Models Blood ·Séverine Cathelin, David Sharon, Amit Subedi, Dan Cojocari, Darren C. Phillips, Joel Johansson, Kyle J. MacBeth, Brandon Nicolay, Rohini Narayanaswamy, Sébastien Ronseaux, Guowen Liu, Steven M. Chan	2018	23
13	Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RARα Dependency Targetable by SY-1425, a Potent and Selective RARα Agonist Cancer Discovery ·Michael R. McKeown, M. Ryan Corces, Matthew L. Eaton, Chris Fiore, Emily Lee, Jeremy T. Lopez, Mei Wei Chen, Darren Smith, Steven M. Chan, Julie L. Koenig, Kathryn Austgen, Matthew G. Guenther, David A. Orlando, Jakob Lovén, Christian Fritz, Ravindra Majeti	2017	89
14	Targeting Mitochondrial Translation Overcomes Venetoclax Resistance in Acute Myeloid Leukemia (AML) through Activation of the Integrated Stress Response Blood ·David Sharon, Séverine Cathelin, Amit Subedi, Ryan Williams, Mariana Benicio, Troy Ketela, Steven M. Chan	2017	2
15	Efficacy of Novel Glutaminase Inhibitor CB-839 in Acute Myeloid Leukemia Blood ·Polina Matre, Maryam Shariati, Juliana Vélez, Yuan Qi, Sergej Konoplev, Xiaoping Su, Courtney D. DiNardo, Naval Daver, Ravindra Majeti, Michael Andreeff, Steven M. Chan, Marina Konopleva	2014	11
16	Role of cysteine 288 in nucleophosmin cytoplasmic mutations: sensitization to toxicity induced by arsenic trioxide and bortezomib Leukemia ·Min Huang, Danièl Thomas, M X Li, Wenli Feng, Steven M. Chan, Ravindra Majeti, Beverly S. Mitchell	2013	28
17	Single‐cell analysis of siRNA‐mediated gene silencing using multiparameter flow cytometry Cytometry Part A ·Steven M. Chan, Janelle A. Olson, Paul J. Utz	2006	5
18	An array of possibilities for the study of autoimmunity Nature ·C. Garrison Fathman, Luis Soares, Steven M. Chan, Paul J. Utz	2005	72
19	Protein microarrays for multiplex analysis of signal transduction pathways Nature Medicine ·Steven M. Chan, Joerg Ermann, Leon Su, C. Garrison Fathman, Paul J. Utz	2004	159
20	Murine CD4+CD25+ Regulatory T Cells Fail to Undergo Chromatin Remodeling Across the Proximal Promoter Region of the IL-2 Gene The Journal of Immunology ·Leon Su, Rémi J. Creusot, Elena Gallo, Steven M. Chan, Paul J. Utz, C. Garrison Fathman, Joerg Ermann	2004	55

About Steven M. Chan

Steven M. Chan is a scholar working on Hematology, Genetics, Cancer Research, Molecular Biology and Public Health, Environmental and Occupational Health, having authored 94 papers that have together received 3.7k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (50 papers), Acute Lymphoblastic Leukemia research (19 papers), Chronic Myeloid Leukemia Treatments (14 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers), Cancer Genomics and Diagnostics (10 papers), Epigenetics and DNA Methylation (10 papers), Protein Degradation and Inhibitors (8 papers) and Histone Deacetylase Inhibitors Research (8 papers). The work is most often cited by research in Hematology (1.4k citations), Cancer Research (840 citations), Genetics (376 citations), Molecular Biology (2.4k citations) and Immunology (558 citations). Steven M. Chan has collaborated with scholars based in Canada, United States and India. Frequent co-authors include Ravindra Majeti, Paul J. Utz, M. Ryan Corces, Bruno C. Medeiros, Scott V. Bratman, David W. Cescon, Lillian L. Siu, Danièl Thomas, Julie L. Koenig and Jason D. Buenrostro. Their work appears in journals such as Blood, Leukemia, Nature Medicine, British Journal of Haematology and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact